Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 31, 2016PLoS ONEOpen Access

A Novel Physiological Glycosaminoglycan-Deficient Splice Variant of Neuropilin-1 Is Anti-Tumorigenic In Vitro and In Vivo

View Full Paper
Ask AI
Bookmark
Share

Authors

CHCéline HendricksUniversity of LiègeJDJohanne DubailInsermLBLaura BrohéeUniversity of Liège

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hendricks et al. (2016) studied this question.

synapsesocial.com/papers/6aaba4ea5185c35e91ca2e43https://doi.org/10.1371/journal.pone.0165153
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Repetitive Ser-Gly Sequences Enhance Heparan Sulfate Assembly in Proteoglycans1995 · 148 citations
  2. 2VEGF/NRP-1 axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin2016 · 158 citations
  3. 3Neuropilin-1–Dependent Regulation of EGF-Receptor Signaling2012 · 117 citations